The 8th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “WHO targets and programs for HBV and HCV: Global and Asian Perspectives” Speaker: Dr. Mukta Sharma You can see the whole slides below the video.
The 7th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Research and new drug discovery in HBV- has it taken back seat in COVID-19 era?” Speaker: Dr. Stephen Locarnini You can see the whole slides below the video.
The 6th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “HBV immunization services during COVID-19 pandemic- Guidance” Speaker: Dr. Saeed Hamid You can see the whole slides below the video.
The 5th presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “COVID-19 and viral hepatitis B and C elimination programs: Are we stepping backward? “Speaker: Dr. Ji Dong JiaYou can see the whole slides below the video.
The 3rd presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Selection of treatment modalities in patients infected with chronic HBV in COVID-19 pandemic era [antivirals or interferons]”Speaker: Dr. Tawesak TanwandeeYou can see the whole slides below the video.
The 2nd presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Assessment for treatment candidacy of patients infected with chronic HBV in COVID-19 pandemic era”Speaker: Dr. Anna Lok You can see the whole slides below the video.
The 1st presentation of APASL-WGO Virtual Summit is available on YouTube! Topic: “Changing epidemiology of HBV in 2020”Speaker: Dr. Cihan YurdaydinYou can see the whole slides below the video.
Join us for the first-ever hybrid APASL congress! The 30th Asian Pacific for The Study of Liver (APASL) 2021 will be held from 4 to 6 February 2021. 【APASL 2021 Annual Meeting】 place: Bangkok, Thailand Homepage: https://www.apasl2021bangkok.org/ President: Dr. Tawesak Tanwandee Register: https://www.apasl2021bangkok.org/registration *Please register at the online form above. Click HERE for further information.
The APASL-WGO Virtual Summit will be held on July 28! 【The APASL-WGO Virtual Summit】 Date: Tuesday, July 28th 2020Time: 16:00-19:30 (IST=+5:30GMT)Place: Online (Zoom)Register Online: https://regconf.com/apasl_wgo_virtual_summit/ *Please register at the online form above. Or, you may just go to following URL and enter with ID/PW to join the webinar. URL: https://zoom.us/joinID: 815 9148 3044PW: apasl2020
The APCOLIS Study (APASL COVID‑19 Liver Injury Spectrum Study) has published a new article! You can also see the article HERE in Hepatology International.
Do join the ‘APCOLIS-II’ Study of APASL CLD Attitudes and Practices during COVID-19 [CLAP-COVID] Study Dear Colleague, We want to thank you for your continued support and active participation in APASL COVID-19 Liver Injury Spectrum Study (APCOLIS-I) study. The manuscript based on the initial 408 patients is under review. The APASL Covid Task Force had made great efforts to prepare the Guidance for SARS-CoV-2 treatment in patients with liver disease. However, a lot of the recommendations were based on expert opinions. In order to further refine the Hepatology Parctices for future, the Task Force has decided to coduct another survey and get inputs from specialists across the world on management of COVID-19 disease in patients … [Read more]
The Digital International Liver Congress™ 2020 is coming up!At the Digital International Liver Congress™ 2020, EASL is turning its attention to health in daily life and its importance in protecting the liver. Doctors, patients and patient groups, allied health professionals, and policymakers will discuss important new insights and information to help combat liver disease. Attendees will hear the latest epidemiological and real-world data on the latest liver research. Date: 27-29 August, 2020Click HERE to access the homepage.
Dear colleague, During the ongoing SARS-CoV-2 pandemic, the Hepatology community remains deeply concerned about acute liver injury developing in healthy individuals and patients with chronic liver disease/cirrhosis. To study the spectrum of Liver Injury due to SARS-CoV-2 infection, the APASL initiated the ‘APCOLIS’ study, wherein the data was provided of such patients, including the natural course, effect of different drugs and therapies on liver functions and outcome. We want to thank you for your continued support and active participation. We were able to collect the data of 408 patients till the beginning of April. The manuscript based on this data has been submitted and is under review. To our delight, we are regularly getting new cases from a large number of … [Read more]
Thank you for taking part on our APASL COVID-19 Webinar!The video of session 7 is now available on APASL YouTube channel.You can also find the slides of following presentations below the linked video. Topic: “To understand sytokine storm in COVID-19” Speakers: Dr. Antonio Bertoletti (Singapore) Topic: “COVID-19 in Asia-Pacific” Speakers: Dr. Simon Stresser (Australia) Topic: “COVID-19 in TURKEY” Speakers: Dr. A. Kardir Dokmeci (Turkey)
Clinical practice guidance of APASL COVID-19 Task Force is now available. You can download the PDF file HERE.
APASL Instagram account has been opened. We will inform you regarding any updates of our official homepage. Please click @apasl_official to visit our Instagram account.Follow us on Instagram!
We have uploaded the past APASL COVID-19 webinars on the Internet. You can visit the following pages to check our webinars. 1. APASL official YouTube channel Please click HERE to see our playlist of APASL COVID-19 Webinar. 2. For our Chinese members: Please click HERE.
4 articles on COVID-19 and the liver have been published online in Hepatology International. 1. Editorial: Fast, faster, and fastest: science on the run during COVID-19 drama”—”do not forget the liver: https://link.springer.com/article/10.1007/s12072-020-10042-0 2. Consensus: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation: https://link.springer.com/article/10.1007/s12072-020-10043-z 3. Guidelines: Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI): https://link.springer.com/article/10.1007/s12072-020-10041-1 4. SARS-Cov-2 (human) and COVID-19: Primer 2020 https://link.springer.com/article/10.1007/s12072-020-10049-7
The 7th APASL COVID-19 Webinar will be held on May 23 (Sat)!Date: May 23 (Sat), 2020 at 4:00-4:45pm Beijing TimeTopic: “To understand cytokine storm in COVID-19”Speaker: Antonio Bertoletti (Singapore) Register at https://regconf.com/apasl_webinar/ [Complimentary]
Thank you for watching our video APASL COVID-19 Webinar!The video of session 6 is now available on APASL YouTube.You can find the slides of this presentation below. Topic: “The Clinical and Immunological Characteristics of COVID-19 in Critical Patients” Speakers: Dr. Cao Bin(Beijing), Dr. Qin Ning(Wuhan)